Cited by

• Clinical evaluation of the antibody against core protein of hepatitis C virus.

  Ohkoshi S, Watanabe M, Kuwana K, Tawaraya H, Kamimura T, Asakura H. Ohkoshi S, et al. Gastroenterol Jpn. 1993 May;28 Suppl 5:80-3. doi: 10.1007/BF02989212. Gastroenterol Jpn. 1993. PMID: 7689513
• Analysis of discordant test results among five second-generation assays for anti-hepatitis C virus antibodies also tested by polymerase chain reaction-RNA assay and other laboratory and clinical tests for hepatitis.

  Nakagiri I, Ichihara K, Ohmoto K, Hirokawa M, Matsuda N. Nakagiri I, et al. J Clin Microbiol. 1993 Nov;31(11):2974-80. doi: 10.1128/jcm.31.11.2974-2980.1993. J Clin Microbiol. 1993. PMID: 7505293 Free PMC article.
• Detection of antibodies to 65 KD heat shock protein and to human superoxide dismutase in autoimmune hepatitis-molecular mimicry between 65 KD heat shock protein and superoxide dismutase.

  Miyata M, Kogure A, Sato H, Kodama E, Watanabe H, Ohira H, Kuroda M, Takagi T, Sato Y, Kasukawa R. Miyata M, et al. Clin Rheumatol. 1995 Nov;14(6):673-7. doi: 10.1007/BF02207935. Clin Rheumatol. 1995. PMID: 8608687
• Seroprevalence of antibody against hepatitis C virus (anti-HCV) in various groups of individuals in Korea.

  Park YM, Kim IS, Lee CD, Kim BS. Park YM, et al. Gastroenterol Jpn. 1991 Jul;26 Suppl 3:159-63. doi: 10.1007/BF02779289. Gastroenterol Jpn. 1991. PMID: 1909258
• Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

  Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, Follett EA, Yap PL, Marsden H. Simmonds P, et al. J Clin Microbiol. 1993 Jun;31(6):1493-503. doi: 10.1128/jcm.31.6.1493-1503.1993. J Clin Microbiol. 1993. PMID: 7686182 Free PMC article.